ExomeDx™ Rapid

NY Approved

Test Overview

Formerly known as XomeDxXpress-trio

Clinical Utility

  • Determination of a clinical diagnosis
  • Identification of gene implicated in genetic disease
  • Recurrence risk assessment

Test Details

Lab Method

  • Next-Gen Sequencing

Ordering Information

Important Information

The ExomeDx Rapid test is whole exome sequencing with an expedited turnaround time (TAT) of approximately 2 weeks. A provisional result is given within 7 calendar days after the start of testing and will include pathogenic and/or expected pathogenic variants in known disease-causing genes definitively explaining the patient’s phenotype. A written report including all clinically relevant variants will be reported within approximately 2 weeks after the start of testing. Because of the rapid TAT, samples on the proband and both biological parents must be submitted at the same time, along with clinical information, in order to begin testing.

To ensure that family members are linked properly and in a timely manner, be sure to provide the following information on the test order and Sample Info Card submitted with the sample:

  • Family member Name
  • Family member Date of Birth
  • Patient's Name
  • Patient's Date of Birth
  • Family member's relationship to patient

Please email [email protected] to discuss prior to sending in samples

Insurance billing not accepted

Trio — Test Code: 896a · CPT Codes*: 81415x1 ,81416x2
Duo — Test Code: 896e · CPT Codes*: 81415x1, 81416x1
Proband — Test Code: 896b · CPT Codes*: 81415x1
ABN Required: No
Turnaround Time**: Provisional result in 7 days; final report ~2 weeks
Preferred Specimen: 3-6 mL Blood - Lavender Top Tube
Alternative Specimen: Buccal Swabs

*The CPT codes provided are based on AMA guidelines and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payer being billed.

**Turnaround times are estimates and begin once the sample(s) begin processing at the GeneDx lab and could be extended in situations outside GeneDx’s control.

Resources